ADT
55
-3
UNP
42
-4
EQR
53
-7
MUR
48
3
DGX
39
-9
NUE
53
-5
EXR
55
-4
ZION
67
-4
WYNN
41
9
SWKS
36
3
CB
55
2
DFS
64
-3
NSC
57
-7
VMC
59
-4
MCK
73
-2
TSN
50
2
DIS
68
6
RSG
70
-7
M
36
5
LEG
37
6
ADT
55
-3
UNP
42
-4
EQR
53
-7
MUR
48
3
DGX
39
-9
NUE
53
-5
EXR
55
-4
ZION
67
-4
WYNN
41
9
SWKS
36
3
CB
55
2
DFS
64
-3
NSC
57
-7
VMC
59
-4
MCK
73
-2
TSN
50
2
DIS
68
6
RSG
70
-7
M
36
5
LEG
37
6
Financhill
Back

Halozyme Therapeutics Vs. Leidos Holdings Industry Stock Comparison

Buy
59

HALO
Halozyme Therapeutics

Last Price:
46.97
Seasonality Move:
17.03%
Sell
40

LDOS
Leidos Holdings

Last Price:
165.00
Seasonality Move:
2.48%
Buy
59
Halozyme Therapeutics (HALO) is a Buy

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $53.96. The Score for HALO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • HALO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Leidos Holdings (LDOS) is a Sell

Is Leidos Holdings a Buy, Sell or Hold?

  • The current Leidos Holdings [LDOS] share price is $167.96. The Score for LDOS is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • LDOS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $53.96
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

LDOS Stock Price Chart

What is Leidos Holdings's stock price today?

  • The Leidos Holdings share price today is $167.96
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LDOS is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.97 Buy
Relative Strength Index (14 RSI): 44.03 Sell
Chaikin Money Flow: -3061675 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.54 - 58.48) Sell
Bollinger Bands (100): (52.34 - 60.32) Sell

LDOS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.47 Buy
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: -4188569 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (166.87 - 191.75) Sell
Bollinger Bands (100): (144.85 - 173.49) Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 59.17 Sell
20-day SMA: 54.83 Sell
50-day SMA: 56.49 Sell
200-day SMA: 48.87 Buy
8-day EMA: 57.67 Sell
20-day EMA: 56.44 Sell
50-day EMA: 56.05 Sell
200-day EMA: 50.78 Buy

LDOS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 192.54 Sell
20-day SMA: 182.33 Sell
50-day SMA: 169.14 Sell
200-day SMA: 146.05 Buy
8-day EMA: 188.31 Sell
20-day EMA: 183.52 Sell
50-day EMA: 172.61 Sell
200-day EMA: 148.04 Buy

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.66 per share.

Leidos Holdings Earnings Growth & LDOS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.05 per share, and an increase next year of $0.31 per share.

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Leidos Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):